Sherbrooke Park Advisers’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$54K	Sell	10,172 -16,638	-62%	-$88.3K	0.02%	496
2025 Q1	$238K	Buy	+26,810	New	+$238K	0.11%	378
2024 Q4	–	Sell	-22,413	Closed	-$614K	–	1028
2024 Q3	$614K	Buy	+22,413	New	+$614K	0.14%	234